Tofersen, an antisense oligonucleotide, reduces SOD1 expression by promoting the ribonuclease (RNase)-mediated degradation of SOD1 mRNA (messenger RNA), showing significant effects on ALS biomarkers [11, 12]. Here, SOD1 is linked to amyotrophic lateral sclerosis.